Deletion of Topoisomerase 1 in excitatory neurons causes genomic instability and early onset neurodegeneration

Nat Commun. 2020 Apr 23;11(1):1962. doi: 10.1038/s41467-020-15794-9.


Topoisomerase 1 (TOP1) relieves torsional stress in DNA during transcription and facilitates the expression of long (>100 kb) genes, many of which are important for neuronal functions. To evaluate how loss of Top1 affected neurons in vivo, we conditionally deleted (cKO) Top1 in postmitotic excitatory neurons in the mouse cerebral cortex and hippocampus. Top1 cKO neurons develop properly, but then show biased transcriptional downregulation of long genes, signs of DNA damage, neuroinflammation, increased poly(ADP-ribose) polymerase-1 (PARP1) activity, single-cell somatic mutations, and ultimately degeneration. Supplementation of nicotinamide adenine dinucleotide (NAD+) with nicotinamide riboside partially blocked neurodegeneration, and increased the lifespan of Top1 cKO mice by 30%. A reduction of p53 also partially rescued cortical neuron loss. While neurodegeneration was partially rescued, behavioral decline was not prevented. These data indicate that reducing neuronal loss is not sufficient to limit behavioral decline when TOP1 function is disrupted.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cerebral Cortex / enzymology
  • Cerebral Cortex / pathology
  • DNA Damage
  • DNA Topoisomerases, Type I / deficiency*
  • DNA Topoisomerases, Type I / genetics
  • Genomic Instability*
  • Hippocampus / enzymology
  • Hippocampus / pathology
  • Inflammation
  • Mice
  • Mice, Knockout
  • Mortality, Premature
  • Motor Activity
  • Mutation
  • NAD / administration & dosage
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / enzymology*
  • Neurodegenerative Diseases / pathology
  • Neurodegenerative Diseases / physiopathology
  • Neurons / drug effects
  • Neurons / enzymology*
  • Neurons / pathology
  • Niacinamide / administration & dosage
  • Niacinamide / analogs & derivatives
  • Poly (ADP-Ribose) Polymerase-1 / metabolism


  • nicotinamide-beta-riboside
  • NAD
  • Niacinamide
  • Parp1 protein, mouse
  • Poly (ADP-Ribose) Polymerase-1
  • DNA Topoisomerases, Type I